HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Factors predicting neuronal surface antibodies in the elderly with new-onset and unknown seizures.

AbstractOBJECTIVE:
To investigate risk factors of neuronal surface antibodies (NSAbs) and develop a nomogram that could identify patients at the odds of NSAbs among the elderly (aged 60 years or older) with new-onset seizures of unknown etiology.
METHODS:
Clinical data for aged ≥60 years diagnosed with new-onset seizures of unknown etiology were retrospectively reviewed. A nomogram based on multivariable logistic regression was constructed. Model performance of nomogram was evaluated using area under the curve (AUC), calibration curve, decision curve analysis (DCA), and clinical impact curve (CIC). Meanwhile, it was internally validated by bootstrap validation in current cohort.
RESULTS:
Of 147 patients included in final analysis, 68 (46.3%) had NSAbs-mediated encephalitis. Six factors were identified: duration of seizures less than 3 months (OR:14.259; 95% CI: 4.480-45.386), focal-onset seizures (OR:12.457; 95% CI: 2.710-57.261), psychiatric deficits (OR:10.063; 95% CI: 3.231-31.343), sleep disorders (OR:3.091; 95% CI: 1.011-9.454), hyponatremia (OR:6.252; 95% CI: 1.445-27.043), and medial temporal lobe (MTL) lesions on MRI (OR:4.102; 95% CI: 1.382-12.169). The nomogram had a good discrimination with an AUC of 0.916 and with a corrected AUC of 0.881 after the bootstrapping validation, our model also exhibited a better predictive performance than scoring systems commonly used clinically. Additionally, the calibration curve showed that predicted NSAbs-positive rates of nomogram were closely aligned with actual observed results. Moreover, the nomogram achieved well on clinical utility by using the DCA and CIC.
INTERPRETATION:
Our nomogram may provide a convenient and useful tool for identifying the elderly with new-onset seizures of unknown etiology who are at risk of NSAbs-mediated encephalitis, which would allow these patients receive earlier immunotherapy.
AuthorsXiao Liu, Tingting Yu, Jing Qi, Ruijuan Lv, Qun Wang
JournalAnnals of clinical and translational neurology (Ann Clin Transl Neurol) Vol. 9 Issue 7 Pg. 1039-1049 (07 2022) ISSN: 2328-9503 [Electronic] United States
PMID35598111 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Topics
  • Aged
  • Area Under Curve
  • Encephalitis
  • Humans
  • Retrospective Studies
  • Seizures (etiology)
  • Temporal Lobe

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: